Rekvina Labs MD Amit Shah resigns; registered office shifts to Vadodara

scanx
Reviewed by
Ashish TScanX News Team
Key Highlights
  • Rekvina Laboratories Limited announced the resignation of Managing Director Amit Shah effective September 11, 2026
  • The resignation was attributed to personal reasons and personal commitments by the director
  • The Board also approved a change in the registered office address within Vadodara effective September 23, 2026
  • Amit Shah held no directorships in other listed entities as per the disclosure
powered bylight_fuzz_icon
51719339

*this image is generated using AI for illustrative purposes only.

Rekvina Laboratories Limited reported the resignation of its Managing Director, Amit Shah, with effect from September 11, 2026. The development was disclosed in a filing to the BSE following a board meeting held on September 23, 2026.

The company stated that Shah resigned citing personal reasons and personal commitments. The resignation was noted by the Board of Directors during their meeting, which commenced at 6:30 pm and concluded at 7:30 pm.

Leadership Change Details

The filing provided specific details regarding the departure of the Managing Director. The table below outlines the key particulars disclosed:

Particulars Details
Name of Director Amit Shah
Designation Managing Director
Date of Resignation September 11, 2026
Effective Date September 11, 2026
Reason Personal reasons and commitments
Other Listed Directorships Not applicable

The disclosure confirmed that Shah held no directorships or committee memberships in other listed entities, nor were there any disclosed relationships between directors relevant to this appointment.

Registered Office Update

In addition to the leadership change, the Board approved a change in the company's registered office within the same city, effective September 23, 2026. The new address is located at 3rd Floor, 5 Laxmi Society, B/h Baroda Heart Institute, Near Haribhakti Colony, Old Padra Road, Vadodara – 390007.

The previous registered office was situated at 36, Sampatrao Colony, Next to Royal Hotel, Alkapuri, Baroda. This administrative update was adopted alongside the acceptance of the Managing Director's resignation.

Historical Stock Returns for Rekvina Laboratories

1 Day5 Days1 Month6 Months1 Year5 Years
-2.00%-10.99%+24.50%+58.11%0.0%0.0%

Who has been appointed as the interim or permanent successor to Amit Shah, and what is their background in the pharmaceutical sector?

How might the sudden leadership change impact Rekvina Laboratories' ongoing strategic initiatives and R&D pipeline?

What are the potential implications of the registered office relocation on the company's operational logistics and regulatory compliance?

Rekvina Laboratories accepts resignation of MD Amit Mukesh Shah

scanx
Reviewed by
Jubin VScanX News Team
Key Highlights
  • Rekvina Laboratories accepts resignation of Amit Mukesh Shah as MD and Director
  • Effective date of resignation is September 11, 2026
  • Cited reason is personal commitments and personal reasons
  • Filing made to BSE under Regulation 30 of SEBI Listing Regulations
powered bylight_fuzz_icon
50770317

*this image is generated using AI for illustrative purposes only.

Rekvina Laboratories has accepted the resignation of Amit Mukesh Shah from the positions of Managing Director and Director, effective September 11, 2026.

The company disclosed the development in a filing with the Bombay Stock Exchange on September 12, 2026. The intimation was issued pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

Resignation Details

Mr. Shah tendered his resignation due to personal reasons and personal commitments. In his letter to the Chairman, dated September 11, 2026, he confirmed that his departure is solely attributable to these factors and stated there are no other reasons for his resignation.

The Board of Directors formally accepted the resignation through a communication signed by Surbhit Mukesh Shah, Director, on September 12, 2026. The filing included details required under SEBI Circular No. SEBI/HO/CFD/CFD-PoD-1/P/CIR/2023/123 dated July 13, 2023.

No financial data or operational metrics were disclosed in this regulatory filing.

Historical Stock Returns for Rekvina Laboratories

1 Day5 Days1 Month6 Months1 Year5 Years
-2.00%-10.99%+24.50%+58.11%0.0%0.0%

Who has been appointed or nominated as the interim Managing Director to ensure operational continuity during the transition?

Will Rekvina Laboratories initiate a search for a permanent replacement for Amit Mukesh Shah, and what is the expected timeline for this process?

How might this leadership change impact the company's ongoing strategic initiatives or R&D pipeline at Rekvina Laboratories?

More News on Rekvina Laboratories

1 Year Returns:0.00%